During the typing of the virus strains isolated in Japan4) active virus vaccine was prepared and injected for immunization, which caused unexpected rise of fever followed by paralysis in some monkeys. These paralyzed monkeys were treated with GLC and responded favorably to the treatment.
The monkeys treated were all survived, though with recidual paralysis. 
RESULTS

GLC-B, treatment for monkeys paralyzed due to active virus immunization
Out of the 12 monkeys intramuscularly vaccinated with active virus, 7 developed typical paralysis.
Out of the paralyzed animals, 3 received the GLC treatment and the rest remained untreated to follow up the natural course. 1-3 mg of GLC was intrathecally injected every other day in the treated group. The 4 monkeys in the untreated group had rise of fever in about 6-11 days after the inoculation and developed the following paralysis about 7-11 days after inoculation ( Table 1) .
Three of them died within 4 days after the onset of paralysis, that is, on the 8-15th day of the disease.
The last monkey died in 34 days after the onset of paralysis.
The start of the treatment for the 3 monkeys mentioned above was about 14-17th day of the inoculation. In these monkeys fever stage started 6-10 days and paralysis 7-12 days after inoculation, and GLC treatment was started in 4-7 days after the onset of paralysis.
The three responded favorably to some extent, and showed improvement in recidual paralysis.
It may be said, however, that GLC treatment was attempted 4-7 days after the onset of paralysis, while the monkeys of non-treated control groups died all within 4 days after the onset of paralysis, which may suggest the situation that the monkeys in the 2. GLC Treatment for the paralyzed monkeys following the challenge with "Brunhilde" strain
Fourteen monkeys immunized with the various strains to be classified were challenged with "Brunhilde" strain 10-2.5 dilution of the infected spinal cord.
Nine of them developed paralysis and received the treatment. Three monkeys that had been used for titration of challenge dose, were excluded from the treatment group ( 3. GLC treatment for the monkeys paralyzed after "Leon" challenge Nine monkeys were immunized with the various strains to be classified as mentioned above, and then challenged with "Leon" strain.
Out of 9 monkeys, 6 had been challenge with "Brunhilde" and survived; three did not developed paralysis and the other three were treated with GLC and survived. Due to "Leon" challenge 5 monkeys out of all 9 were paralyzed.
Four out of the 5 paralyzed monkeys received the treatment (3 mg GLC and 5 mg VB1 every time), and the last one that was also paralyzed was observed without treatment, together with another non-immunized monkey as control.
As shown in the table, the 2 untreated monkeys developed paralysis in 6-10 days, died in 7-20 days after inoculation.
While the monkeys of the treated group developed paralysis in 6-8 days after inoculation and one of them died on the 10th after inoculation.
The rest receiving GLC 16-24 times survived with recidual paralysis ( 
